Literature DB >> 21449948

Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation.

D K de Vries1, J H N Lindeman, J Ringers, M E J Reinders, T J Rabelink, A F M Schaapherder.   

Abstract

Donor brain death has profound effects on post-transplantation graft function and survival. We hypothesized that changes initiated in the donor influence the graft's response to ischemia and reperfusion. In this study, human brain dead donor kidney grafts were compared to living and cardiac dead donor kidney grafts. Pretransplant biopsies of brain dead donor kidneys contained notably more infiltrating T lymphocytes and macrophages. To assess whether the different donor conditions result in a different response to reperfusion, local cytokine release from the reperfused kidney was studied by measurement of paired arterial and renal venous blood samples. Reperfusion of kidneys from brain dead donors was associated with the instantaneous release of inflammatory cytokines, such as G-CSF, IL-6, IL-9, IL-16 and MCP-1. In contrast, kidneys from living and cardiac dead donors showed a more modest cytokine response with release of IL-6 and small amounts of MCP-1. In conclusion, this study shows that donor brain death initiates an inflammatory state of the graft with T lymphocyte and macrophage infiltration and massive inflammatory cytokine release upon reperfusion. These observations suggest that brain dead donors require a novel approach for donor pretreatment aimed at preventing this inflammatory response to increase graft survival. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449948     DOI: 10.1111/j.1600-6143.2011.03466.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  25 in total

1.  Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs.

Authors:  Yong Qiang; Guiyou Liang; Limei Yu
Journal:  Lab Invest       Date:  2016-02-29       Impact factor: 5.662

2.  Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Marlies E J Reinders; Ellen Lievers; Jan Ringers; Jan H N Lindeman; Alexander F M Schaapherder
Journal:  Inflamm Res       Date:  2012-09-13       Impact factor: 4.575

3.  Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.

Authors:  F Cicora; J Roberti; D Vasquez; D Guerrieri; N Lausada; P Cicora; G Palti; E Chuluyan; P Gonzalez; P Stringa; C Raimondi
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 4.  Acute Kidney Injury at the Neurocritical Care Unit.

Authors:  Gonzalo Ramírez-Guerrero; Romyna Baghetti-Hernández; Claudio Ronco
Journal:  Neurocrit Care       Date:  2021-09-13       Impact factor: 3.210

Review 5.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

Review 6.  Ischaemic and inflammatory injury in renal graft from brain death donation: an update review.

Authors:  Anthony Fung; Hailin Zhao; Bob Yang; Qingqian Lian; Daqing Ma
Journal:  J Anesth       Date:  2016-01-08       Impact factor: 2.078

Review 7.  Inflammatory triggers of acute rejection of organ allografts.

Authors:  Daniel N Mori; Daniel Kreisel; James N Fullerton; Derek W Gilroy; Daniel R Goldstein
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

8.  Amelioration of renal damage by administration of anti-thymocyte globulin to potential donors in a brain death rat model.

Authors:  F Cicora; P Stringa; D Guerrieri; J Roberti; N Ambrosi; F Toniolo; P Cicora; G Palti; D Vásquez; C Raimondi
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

9.  No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Mark Roest; Marlies Ej Reinders; Eric P van der Veer; Robert Jm Klautz; Philip G de Groot; Alexander F Schaapherder; Jan H Lindeman
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

10.  Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal.

Authors:  Dorottya K de Vries; Kirsten A Kortekaas; Dimitrios Tsikas; Leonie G M Wijermars; Cornelis J F van Noorden; Maria-Theresia Suchy; Christa M Cobbaert; Robert J M Klautz; Alexander F M Schaapherder; Jan H N Lindeman
Journal:  Antioxid Redox Signal       Date:  2013-03-26       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.